TABLE 4

In vivo human clearance values for n = 9 compounds in this study and the key parameters for prediction

References for plasma clearance data are available at www.capkr.man.ac.uk.


Compound

Observed Plasma Clearance

Number of in Vivo Studies

Number of Individuals

RB

fup
ml/min/kg
S-Warfarin 0.06 1 10 0.55 0.01
Tolbutamide 0.24 6 35 0.75 0.05
Diclofenac 3.8 1 7 0.55 0.01
Quinidine 5.2 4 30 0.87 0.13
Nifedipine 8.1 9 54 0.59a 0.04
Bufuralol 8.8 1 7 0.80 0.19
Mephenytoin 53b 3 35 0.84 0.60
Dextromethorphan 415b 5 72 1.76a 0.50a
Terfenadine
1300b
5
69
1
0.03
  • a Rat data.

  • b CL value determined after oral dosing.